Source: Υπουργείο Υγείας (CY) Revision Year: 2017 Publisher: Merz Pharmaceuticals GmbH, Eckenheimer Landstr. 100, 60318 Frankfurt am Main, Germany Phone: 49-69/1503-1 Fax: 49-69/1503-200
Hypersensitivity to the active substance(s) or to any of the excipients of Pantogar.
No special warnings and precautions are required.
Before starting Pantogar please tell your doctor or pharmacist if you are taking or have recently taken medicines containing sulfonamides.
Animal studies are insufficient to indicate the effect on pregnancy and embryo/fetal development, child-bearing and postnatal development. No hazard for humans is known. During pregnancy and lactation Pantogar must only be prescribed after careful evaluation of the benefit and possible risk ratio.
Pantogar has no or negligible influence on the ability to drive and use machines.
Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Undesirable effects regarding frequency are classified as following: Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1,000 to <1/100), Rare (≥1/10,000 to <1/1,000), Very rare (<1/10,000), Not known (cannot be estimated from the available data).
Frequency is not known: headache and dizziness.
Rare: tachycardia, accelerated pulse.
Frequency is not known: palpitation.
Frequency is not known: diarrhoea, vomiting, abdominal pain, flatulence, heartburn, nausea.
Rare: hives, rash, pruritus.
Frequency is not known: erythema.
Rare: outbreak of sweating.
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via: Pharmaceutical Services, Ministry of Health, 1475, Nicosia, Cyprus, Phone Number:+ 357 608620, FAX: +357 22 608649, E-mail: phscentral@phs.moh.gov.cy.
Interaction with other medicinal products not observed.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
